García-Díaz N, Solli E, Hajjar E, Cornillot-Clément S, Landskron J, Ahmad R, Wei Q, Taskén K(2025) MAPK and STAT3 Inhibitors Modulate FoxP3 Expression and Regulatory T Cell Function Eur J Immunol, 55(2), e202451225 DOI 10.1002/eji.202451225, PubMed 39955647
Arseni L, Sigismondo G, Yazdanparast H, Hermansen JU, Mack N, Ohl S, Kalter V, Iskar M, Kalxdorf M, Friedel D, Rettel M, Paul Y, Ringshausen I, Eldering E, Dubois J, Kater AP, Zapatka M, Roessner PM, Tausch E, Stilgenbauer S, Dietrich S, Savitski MM, Skånland SS, Krijgsveld J, Lichter Pet al.(2025) Longitudinal omics data and preclinical treatment suggest the proteasome inhibitor carfilzomib as therapy for ibrutinib-resistant CLL Nat Commun, 16(1), 1041 DOI 10.1038/s41467-025-56318-7, PubMed 39863584
Posadas-Cantera S, Mitsuiki N, Emmerich F, Patiño V, Lorenz HM, Neth O, Dybedal I, Taskén K, Schäffer AA, Grimbacher B, Gámez-Díaz L(2025) The effect of HLA genotype on disease onset and severity in CTLA-4 insufficiency Front Immunol, 15, 1447995 DOI 10.3389/fimmu.2024.1447995, PubMed 39835139
